Who is sponsoring NCT02427724?

NCT02427724 is sponsored by Northwestern University.

What drugs are being tested in NCT02427724?

Interventions: lidocaine 2.5%/prilocaine 2.5% topical anesthetic, lidocaine 7%/tetracaine 7% topical anesthetic, placebo vehicle, Q-switched 532nm Laser.

What is the status of NCT02427724?

NCT02427724 is currently ACTIVE_NOT_RECRUITING.

Last reviewed 2025-01-29 · How we verify

The Effect of Topical Anesthetic Using Lidocaine 2.5%/Prilocaine 2.5% Versus Lidocaine 7%/Tetracaine 7% Cream on Patients' Pain and Operative Experience During Treatment With QSwitched 532nm Laser

NCT02427724 EARLY_PHASE1 ACTIVE_NOT_RECRUITING

This study will conduct a split-face and -body randomized control trial to compare lidocaine 2.5%/prilocaine 2.5% topical anesthetic (LPTA), lidocaine 7%/tetracaine 7% topical anesthetic (LTTA), and placebo vechicle (PV) on patients' pain perceptions with Q-switched 532nm laser for the treatment of lentigines and/or photorejuvenation.Subjects will fill out a pain score on a visual analog scale (VAS) with 0 being no pain and 10 being most pain after each treatment area is completed.

Details

Lead sponsor	Northwestern University
Phase	EARLY_PHASE1
Status	ACTIVE_NOT_RECRUITING
Enrolment	48
Start date	2015-04
Completion	2025-12

Conditions

Lentigo

Interventions

lidocaine 2.5%/prilocaine 2.5% topical anesthetic
lidocaine 7%/tetracaine 7% topical anesthetic
placebo vehicle
Q-switched 532nm Laser

Primary outcomes

visual analog score (VAS) pain rating — Day of treatment
Subjects will fill out a visual analog score (VAS) pain rating after treatment with 0 being no pain and 10 being worst pain

Countries

United States